huahaipharm(SH:600521) Jin Rong Jie·2025-08-13 23:29Core Viewpoint - Zhejiang Huahai Pharmaceutical Co., Ltd. has established a new subsidiary, Huahai Tianheng (Shanghai) Pharmaceutical Research Co., Ltd., with an investment of 400 million RMB, focusing on research and experimental development in the pharmaceutical industry [1] Company Summary - Huahai Tianheng (Shanghai) Pharmaceutical Research Co., Ltd. was founded on September 23, 2024, with a registered capital of 400 million RMB and is wholly owned by Zhejiang Huahai Pharmaceutical Co., Ltd. [1] - The company is located in Shanghai and is involved in various activities including medical research and experimental development, import and export of goods and technology, data processing and storage support services, and various technical services [1] - The company is authorized to engage in several licensed activities such as drug production, wholesale, retail, import and export, contract manufacturing, and clinical trial services, subject to regulatory approvals [1] Industry Summary - The establishment of Huahai Tianheng indicates a strategic move within the pharmaceutical industry, emphasizing the importance of research and development in enhancing the company's capabilities and market position [1]